Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Tasigna 150mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Tasigna 150mg :
Type Medicine Authorised
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L01EX08

Your comment will appear shortly after approval

Tasigna 150mg :

Revision Date : 15/12/2014


Effect Frequency
Abdominal discomfort Common
Abdominal distension Common
Abdominal pain Common
Abdominal pain upper Very Common
Acne Common
Alopecia Very Common
ALT increased Very Common
Amnesia Not known
Amylase increased Common
Anaemia Not known
Anal abscess Not known
Angina pectoris Common
Anxiety Common
Appetite disorder Not known
Arrhythmia Common
Arteriosclerosis Uncommon
Arthralgia (Pain joint) (Joint ache) Common
Arthritis Not known
AST increased Very Common
Asthenia Common
Atrial fibrillation Common
Atrioventricular block (AVB) Common
Back pain Common
Basilar artery stenosis Not known
Blepharitis Not known
Blister Not known
Blood alkaline phosphatase increased Common
Blood bilirubin increased Very Common
Blood bilirubin unconjugated increased Not known
Blood cholesterol increased Very Common
Blood creatine phosphokinase increased Common
Blood glucose decreased Uncommon
Blood insulin decreased Not known
Blood insulin increased Common
Blood lactate dehydrogenase increased Uncommon
Blood parathyroid hormone increased Not known
Blood phosphorus decreased Very Common
Blood triglycerides increased Very Common
Blood urea increased Uncommon
Bone pain Common
Bradycardia Common
Breast induration Not known
Breast pain Uncommon
Bronchitis Uncommon
Bundle branch block left Not known
Candidiasis (Candida infection) Uncommon
Cardiac failure Uncommon
Cardiac flutter Common
Cardiac murmur Uncommon
Cerebral infarction Uncommon
Cerebral oedema (Brain oedema) Not known
Cerebrovascular accident Not known
Chest discomfort Common
Chest pain Common
Chills Uncommon
Chorioretinopathy Not known
Chromaturia Not known
Confusional state Not known
Conjunctival haemorrhage Common
Conjunctival hyperaemia (Conjunctival redness) (Conjunctival injection) Common
Conjunctivitis Common
Conjunctivitis allergic Not known
Constipation Common
Contusion Common
Coronary artery disease Uncommon
Cough Common
Cyanosis Uncommon
Decreased appetite Common
Dehydration Uncommon
Depression Common
Dermal cyst Not known
Dermatitis Common
Dermatitis acneiform Common
Dermatitis allergic Common
Dermatitis exfoliative Common
Diabetes mellitus Common
Diarrhoea (Diarrhea) Common
Diastolic dysfunction Not known
Diplopia Not known
Disorientation Not known
Dizziness Common
Drug eruption Uncommon
Dry eye Common
Dry mouth (Xerostomia) Not known
Dry skin Common
Dysaesthesia Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Dyslipidaemia Uncommon
Dyspepsia Common
Dysphonia Common
Dyspnoea (dyspnea) Common
Dyspnoea exertional Not known
Dysuria (Micturition painful) Not known
Ecchymosis Uncommon
ECG QT prolonged Common
Eczema Common
Ejection fraction decreased Not known
Enterocolitis Not known
Eosinophilia Common
Epistaxis (Nasal bleeding) Not known
Erectile dysfunction Uncommon
Erythema Common
Erythema multiforme Not known
Erythema nodosum Not known
Exfoliative rash Uncommon
Extrasystoles Common
Eye haemorrhage Common
Eye irritation Uncommon
Eye pain Not known
Eye pruritus Common
Eye swelling Not known
Eyelid oedema Common
Face oedema Not known
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Not known
Feeling cold Uncommon
Feeling of body temperature change Uncommon
Flank pain Uncommon
Flatulence Common
Flushing Common
Folliculitis Common
Gamma-GT increased Common
Gastric ulcer Not known
Gastritis Uncommon
Gastroduodenal haemorrhage Uncommon
Gastroenteritis Uncommon
Gastrointestinal ulcer perforation Not known
Gastrooesophageal reflux disease Uncommon
Gingivitis Not known
Globulins decreased Common
Gout Uncommon
Gravitational oedema Uncommon
Gynecomastia (Gynaecomastia) Not known
Haematemesis Not known
Haematoma Not known
Haematuria (Hematuria) Not known
Haemoglobin decreased Common
Haemorrhage intracranial Uncommon
Haemorrhoids Not known
HDL increased Very Common
Headache Very Common
Hepatic function abnormal Common
Hepatitis toxic Not known
Hepatomegaly Not known
Hepatotoxicity (liver toxicity) Not known
Herpes virus infection Not known
Hiatus hernia Not known
Hyperaemia Common
Hyperaesthesia Not known
Hyperbilirubinaemia Very Common
Hypercalcaemia Common
Hypercholesterolaemia Common
Hyperglycaemia Common
Hyperhidrosis Common
Hyperkalaemia Uncommon
Hyperkeratosis Not known
Hyperlipidaemia Common
Hyperparathyroidism secondary Not known
Hyperphosphataemia Common
Hypersensitivity Not known
Hypertension Common
Hypertensive crisis Uncommon
Hyperthyroidism Uncommon
Hypertriglyceridaemia Common
Hyperuricaemia Not known
Hypoacusis Not known
Hypocalcaemia Common
Hypoesthesia Common
Hypoglycaemia Not known
Hypokalaemia (hypokalemia) Common
Hypomagnesaemia (hypomagnesemia) Common
Hyponatraemia (Hyponatremia) Common
Hypophosphataemia (hypophosphatemia) Very Common
Hypotension Not known
Hypothyroidism Uncommon
Increased appetite Uncommon
Influenza-like illness Uncommon
Insomnia Common
Insulin C-peptide decreased Not known
Intermittent claudication Uncommon
Interstitial pneumonitis Uncommon
Ischaemic stroke Uncommon
Jaundice Uncommon
Joint swelling Uncommon
Laryngeal pain Uncommon
LDL Increased Very Common
Lethargy Not known
Leucopenia (Leukopenia) Common
Leukocytosis Uncommon
Lipase increased Very Common
Localised oedema Not known
Loss of consciousness Uncommon
Lymphopenia Common
Malaise Uncommon
Melaena Uncommon
Menorrhagia Not known
Micturition urgency (Urinary urgency) Uncommon
Migraine Uncommon
Mouth ulceration Uncommon
Muscle spasms Common
Muscle weakness Common
Musculoskeletal chest pain Common
Musculoskeletal pain Uncommon
Myalgia Very Common
Myocardial infarction Common
Nasopharyngitis Common
Nausea Very Common
Neuropathy peripheral Common
Neutropenia Common
Night sweats Common
Nipple swelling Not known
Nocturia Uncommon
Non-cardiac chest pain Common
Ocular hyperaemia Common
Ocular surface disease Not known
Oedema peripheral Common
Oesophageal pain Not known
Oesophageal ulcer Not known
Oesophagitis ulcerative Not known
Optic neuritis Not known
Oral candidiasis Not known
Oral papilloma Not known
Oropharyngeal pain Not known
Otalgia (Earache) (Ear pain) Not known
Pain Uncommon
Pain in extremity (Pain in limb) Common
Pain of skin Uncommon
Palpitations Common
Pancreatitis Uncommon
Pancytopenia Uncommon
Papilloedema Not known
Paraesthesia (paresthesia) Uncommon
Paraproteinaemia Not known
Pericardial effusion Not known
Pericarditis Not known
Periorbital oedema Not known
Peripheral arterial occlusive disease Uncommon
Peripheral artery stenosis Not known
Petechiae Not known
Pharyngitis Common
Photophobia Not known
Photopsia Common
Photosensitivity reaction Not known
Pleural effusion Uncommon
Pleurisy (Pleuritis ) Not known
Pneumonia Uncommon
Pollakiuria (Urinary frequency) Not known
Pruritus Very Common
Psoriasis Not known
Pulmonary hypertension Not known
Pulmonary oedema Uncommon
Pyrexia Common
Rectal haemorrhage Not known
Renal failure Not known
Restless legs syndrome Not known
Retroperitoneal haemorrhage Not known
Rhinitis Common
Scleral hyperaemia Common
Sebaceous hyperplasia Not known
Sensation of heat (Feeling of warmth) (Sensation of warmth) Uncommon
Sensitivity of teeth Uncommon
Sepsis (Systemic infection) (Sepsis state) Not known
Shock haemorrhagic Not known
Skin atrophy Not known
Skin discolouration (Dyschromia) Not known
Skin exfoliation (Flaking skin) Not known
Skin hyperpigmentation Not known
Skin hypertrophy Not known
Skin papilloma Common
Skin rash Very Common
Skin ulcer Not known
Stomatitis Not known
Subcutaneous abscess Not known
Subileus Not known
Sudden death Uncommon
Swelling face Not known
Syncope Not known
Tachycardia Common
Throat irritation Uncommon
Thrombocytopenia (Thrombopenia) Not known
Thrombocytosis Uncommon
Thrombosis Not known
Thyroiditis Not known
Tinea pedis Not known
Tremor Not known
Troponin increased Not known
Tumour lysis syndrome Rare
Upper respiratory tract infection Common
Urinary incontinence Not known
Urinary tract infection Uncommon
Urticaria Not known
Ventricular dysfunction Not known
Ventricular extrasystoles Common
Vertigo Common
Vision blurred Not known
Visual acuity reduced Uncommon
Vomiting Common
Weight decreased (Weight loss) Not known
Weight increased (weight gain) Common
Xerophthalmia Common

Different Units By MoH Code

Revision Date : 13/06/2022

Revision Date : 13/06/2022

Tasigna 150mg  MoH 6207 :
Form Capsule, hard
Packaging Blisters (Al/PVC/PVDC)
Package Size Box of 112
Strength 150mg
Public Price 247861853.36 L.L.
Stratum E2
NSSF ✔
Quarantine ✘
Reg. Number 167811/11
Submission date 01/01/2011
Registration Year 2011


Price Comparison

● Country: Qatar
● Package Size: 28
● Public Price: 5056 QAR ( 124,165,248.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 180,5714 QAR ( 4,420,440.00 LBP )
● Pharmacy Price: 4152.62851432 QAR ( 101980251.05467 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 28
● Public Price: 532.28 OMR ( 122,815,093.52 LBP )
● Pack size unit used: 28
● Cost/Unit: 19,01 OMR ( 4,383,946.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 112's [28's Box (4's Blister x 7)] x 4)
● Public Price: 18896 AED ( 456,546,256.00 LBP )
● Pack size unit used: 112
● Cost/Unit: 168,7143 AED ( 4,059,048.00 LBP )
● Pharmacy Price: 16096.69 AED ( 388912127.09 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 112
● Public Price: 18896 AED ( 456,546,256.00 LBP )
● Pack size unit used: 112
● Cost/Unit: 168,7143 AED ( 4,059,048.00 LBP )
● Pharmacy Price: 16096.7 AED ( 388912368.7 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 112
● Public Price: 4629.36 EUR ( 448,473,879.36 LBP )
● Pack size unit used: 112
● Cost/Unit: 41,3336 EUR ( 3,971,916.00 LBP )
● Exfactory Price: 2804.97 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 28
● Public Price: 449.33 BHD ( 106,821,018.22 LBP )
● Pack size unit used: 28
● Cost/Unit: 16,0475 BHD ( 3,803,744.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 112
● Public Price: 16674.7 SAR ( 394,189,908.00 LBP )
● Pack size unit used: 112
● Cost/Unit: 148,8812 SAR ( 3,498,720.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Germany
● Package Size: 4x28
● Public Price: 3820.23 EUR ( 370,088,601.48 LBP )
● Pack size unit used: 112
● Cost/Unit: 34,1092 EUR ( 3,293,784.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 112
● Public Price: 3529.3 CHF ( 365,000,206.00 LBP )
● Pack size unit used: 112
● Cost/Unit: 31,5116 CHF ( 3,206,020.00 LBP )
● Exfactory Price: 3203.24 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 112
● Public Price: 2768.4 JOD ( 346,661,816.40 LBP )
● Pack size unit used: 112
● Cost/Unit: 24,7179 JOD ( 3,005,304.00 LBP )
● Pharmacy Price: 2661.92 JOD ( 333328284.32 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 112
● Public Price: 25613.8 DKK ( 332,364,668.80 LBP )
● Pack size unit used: 112
● Cost/Unit: 228,6946 DKK ( 2,958,528.00 LBP )
● Pharmacy Price: 19038.65 DKK ( 247045522.4 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 112
● Public Price: 3084.1 EUR ( 298,775,271.60 LBP )
● Pack size unit used: 112
● Cost/Unit: 27,5366 EUR ( 2,615,652.00 LBP )
● Pharmacy Price: 3077.1 EUR ( 298097139.6 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 112
● Public Price: 437074 ISK ( 281,912,730.00 LBP )
● Pack size unit used: 112
● Cost/Unit: 3902,4464 ISK ( 2,516,790.00 LBP )
● Pharmacy Price: 346317 ISK ( 223374465 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 112
● Public Price: 2820.57 EUR ( 273,245,539.32 LBP )
● Pack size unit used: 112
● Cost/Unit: 25,1837 EUR ( 2,421,900.00 LBP )
● Pricing Date: 08/10/2020
● Type: Medicine Authorised

● Country: Spain
● Package Size: 112
● Public Price: 2872.56 EUR ( 278,282,122.56 LBP )
● Pack size unit used: 112
● Cost/Unit: 25,6479 EUR ( 2,421,900.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 112
● Public Price: 2432.85 GBP ( 276,490,969.65 LBP )
● Pack size unit used: 112
● Cost/Unit: 21,7219 GBP ( 2,386,629.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 112
● Public Price: 2724.05 EUR ( 263,895,067.80 LBP )
● Pack size unit used: 112
● Cost/Unit: 24,3219 EUR ( 2,325,024.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 112
● Public Price: 2771 EUR ( 268,443,396.00 LBP )
● Pack size unit used: 112
● Cost/Unit: 24,7411 EUR ( 2,325,024.00 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Finland
● Package Size: 112
● Public Price: 2596.28 EUR ( 251,517,221.28 LBP )
● Pack size unit used: 112
● Cost/Unit: 23,1811 EUR ( 2,228,148.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Capsule, hard
● Package Size: Box of 112
● Public Price: 247861853.36 LBP ( 247,861,853.36 LBP )
● Pack size unit used: 112
● Cost/Unit: 2213052,26 LBP ( 2,213,052.00 LBP )
● Pricing Date: 03/09/2026

● Country: Czech Republic
● Package Size: 112
● Public Price: 63075.8 CZK ( 240,886,480.20 LBP )
● Pack size unit used: 112
● Cost/Unit: 563,1768 CZK ( 2,150,097.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Greece
● Package Size: 112
● Public Price: 2383.57 EUR ( 230,910,727.32 LBP )
● Pack size unit used: 112
● Cost/Unit: 21,2819 EUR ( 2,034,396.00 LBP )
● Exfactory Price: 2150.9 EUR
● Pharmacy Price: 2183.16 EUR ( 211495808.16 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 112
● Public Price: 2419.99 EUR ( 234,438,951.24 LBP )
● Pack size unit used: 112
● Cost/Unit: 21,6071 EUR ( 2,034,396.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Norway
● Package Size: 112
● Public Price: 27634.6 NOK ( 223,950,798.40 LBP )
● Pack size unit used: 112
● Cost/Unit: 246,7375 NOK ( 1,993,584.00 LBP )
● Pharmacy Price: 21645.79 NOK ( 175417482.16 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Sweden
● Package Size: 112
● Public Price: 24138.16 SEK ( 202,953,649.28 LBP )
● Pack size unit used: 112
● Cost/Unit: 215,5193 SEK ( 1,807,720.00 LBP )
● Pharmacy Price: 23619.52 SEK ( 198592924.16 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Egypt
● Package Size: Boîte de 112
● Public Price: 4800 EGP ( 8,760,000.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 171,4286 EGP ( 312,075.00 LBP )
● Pricing Date: 02/12/2019
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 112
● Public Price: 10337.33 TRY ( 27,704,044.40 LBP )
● Pack size unit used: 112
● Cost/Unit: 92,2976 TRY ( 246,560.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 120 cap
● Exfactory Price: 4680 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Portugal
● Package Size: 112
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 180,5714 QAR ( 4,420,440.00 LBP )
● Cost/Day: 722,29 QAR ( 17,730,876.00 LBP )
● Cost/Month: 21668,7 QAR ( 532,122,744.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 19,01 OMR ( 4,383,946.00 LBP )
● Cost/Day: 76,04 OMR ( 17,535,784.00 LBP )
● Cost/Month: 2281,2 OMR ( 526,304,254.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 168,7143 AED ( 4,059,048.00 LBP )
● Cost/Day: 674,86 AED ( 16,284,514.00 LBP )
● Cost/Month: 20245,8 AED ( 489,139,445.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 168,7143 AED ( 4,059,048.00 LBP )
● Cost/Day: 674,86 AED ( 16,284,514.00 LBP )
● Cost/Month: 20245,8 AED ( 489,139,445.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 41,3336 EUR ( 3,971,916.00 LBP )
● Cost/Day: 165,33 EUR ( 15,984,540.00 LBP )
● Cost/Month: 4959,9 EUR ( 480,408,084.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 16,0475 BHD ( 3,803,744.00 LBP )
● Cost/Day: 64,19 BHD ( 15,214,976.00 LBP )
● Cost/Month: 1925,7 BHD ( 457,637,950.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 148,8812 SAR ( 3,498,720.00 LBP )
● Cost/Day: 595,52 SAR ( 14,065,800.00 LBP )
● Cost/Month: 17865,6 SAR ( 422,328,600.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 34,1092 EUR ( 3,293,784.00 LBP )
● Cost/Day: 136,44 EUR ( 13,175,136.00 LBP )
● Cost/Month: 4093,2 EUR ( 396,513,468.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 31,5116 CHF ( 3,206,020.00 LBP )
● Cost/Day: 126,05 CHF ( 13,030,920.00 LBP )
● Cost/Month: 3781,5 CHF ( 391,031,020.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 24,7179 JOD ( 3,005,304.00 LBP )
● Cost/Day: 98,87 JOD ( 12,271,658.00 LBP )
● Cost/Month: 2966,1 JOD ( 371,405,486.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 228,6946 DKK ( 2,958,528.00 LBP )
● Cost/Day: 914,78 DKK ( 11,860,064.00 LBP )
● Cost/Month: 27443,4 DKK ( 356,100,368.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 27,5366 EUR ( 2,615,652.00 LBP )
● Cost/Day: 110,15 EUR ( 10,656,360.00 LBP )
● Cost/Month: 3304,5 EUR ( 320,078,304.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 3902,4464 ISK ( 2,516,790.00 LBP )
● Cost/Day: 15609,79 ISK ( 10,067,805.00 LBP )
● Cost/Month: 468293,7 ISK ( 302,048,985.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 25,1837 EUR ( 2,421,900.00 LBP )
● Cost/Day: 100,73 EUR ( 9,687,600.00 LBP )
● Cost/Month: 3021,9 EUR ( 292,662,396.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 25,6479 EUR ( 2,421,900.00 LBP )
● Cost/Day: 102,59 EUR ( 9,881,352.00 LBP )
● Cost/Month: 3077,7 EUR ( 298,087,452.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 21,7219 GBP ( 2,386,629.00 LBP )
● Cost/Day: 86,89 GBP ( 9,773,814.00 LBP )
● Cost/Month: 2606,7 GBP ( 296,169,294.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 24,3219 EUR ( 2,325,024.00 LBP )
● Cost/Day: 97,29 EUR ( 9,396,972.00 LBP )
● Cost/Month: 2918,7 EUR ( 282,684,168.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 24,7411 EUR ( 2,325,024.00 LBP )
● Cost/Day: 98,96 EUR ( 9,493,848.00 LBP )
● Cost/Month: 2968,8 EUR ( 287,527,968.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 23,1811 EUR ( 2,228,148.00 LBP )
● Cost/Day: 92,72 EUR ( 8,912,592.00 LBP )
● Cost/Month: 2781,6 EUR ( 269,412,156.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 2213052,26 LBP ( 2,213,052.00 LBP )
● Cost/Day: 8852209,04 LBP ( 8,852,209.00 LBP )
● Cost/Month: 265566271,2 LBP ( 265,566,271.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 563,1768 CZK ( 2,150,097.00 LBP )
● Cost/Day: 2252,71 CZK ( 8,600,388.00 LBP )
● Cost/Month: 67581,3 CZK ( 258,091,839.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 21,2819 EUR ( 2,034,396.00 LBP )
● Cost/Day: 85,13 EUR ( 8,234,460.00 LBP )
● Cost/Month: 2553,9 EUR ( 247,324,428.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 21,6071 EUR ( 2,034,396.00 LBP )
● Cost/Day: 86,43 EUR ( 8,331,336.00 LBP )
● Cost/Month: 2592,9 EUR ( 251,102,592.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 246,7375 NOK ( 1,993,584.00 LBP )
● Cost/Day: 986,95 NOK ( 7,990,544.00 LBP )
● Cost/Month: 29608,5 NOK ( 239,943,232.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 215,5193 SEK ( 1,807,720.00 LBP )
● Cost/Day: 862,08 SEK ( 7,247,696.00 LBP )
● Cost/Month: 25862,4 SEK ( 217,447,696.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 171,4286 EGP ( 312,075.00 LBP )
● Cost/Day: 685,71 EGP ( 1,250,125.00 LBP )
● Cost/Month: 20571,3 EGP ( 37,542,075.00 LBP )
Newly diagnosed chronic phase, chronic myelogenous leukaemia : (Adults)
● Cost/Unit: 92,2976 TRY ( 246,560.00 LBP )
● Cost/Day: 369,19 TRY ( 988,920.00 LBP )
● Cost/Month: 11075,7 TRY ( 29,681,000.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info